U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07855718) titled 'Serum Soluble BCMA as a Non-Invasive Marker in Multiple Myeloma' on Sept. 28.
Brief Summary: This prospective study aims to investigate serum soluble B-cell maturation antigen (sBCMA) as a non-invasive marker in patients with multiple myeloma and to compare its levels with healthy controls.
Study Start Date: Sept. 30
Study Type: OBSERVATIONAL
Condition:
Multiple Myeloma
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Assiut University
Information provided by (Responsible Party): Naira Amen Ezz Eldeen Ahmed, Assiut University
Disclaimer: Curated by HT Syndication....